ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cutera® Announces the North America Launch of xeo®+

A legacy in the aesthetics industry, xeo+ offers new and innovative features

Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announces the launch of xeo+, a pioneering laser and light-based multi-application platform built on a rich history of excellence in performance and innovation. The xeo+ offers providers updated features and newly redesigned handpieces that allow for faster treatment times, optimized ease of use and an improved treatment experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411765198/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

"xeo® has played a pivotal role in the history of Cutera and I’m proud to be a part of that legacy with the launch of xeo+,” said Michael Karavitis, Ph.D., Executive Vice President, Chief Technology Officer, Cutera. “We developed an innovation inspired by the modern aesthetic practice building upon the over 20-year heritage of xeo. The new xeo+ seamlessly blends versatility and cutting-edge technology to meet the ever-evolving demands of thriving practices and we are confident that xeo+ will surpass our customers' expectations and set a new standard of excellence in the industry.”

Introduced in 2003, xeo pioneered Nd:YAG laser technology as the first 1064 nm laser with contact cooling. Its traction increased with the inclusion of the signature Laser Genesis™ treatment, an exclusive 15-minute skin revitalization treatment for all skin types that utilizes proprietary micropulses to stimulate the skin. Laser Genesis helped to raise the bar for no-downtime treatment protocols and has been widely popular amongst thousands of xeo providers and patients worldwide.

Cutera continues to set industry milestones with the modernized xeo+, designed to deliver a more streamlined approach to aesthetics with faster treatment times, an intuitive user interface and a host of features for an elevated provider and patient experience. The technology is enhanced with larger spot size options and upgraded contact cooling for improved comfort, resulting in faster Laser Genesis™ treatments and allowing practitioners to perform hair removal treatments two times faster than before. The technology also includes a versatile range of newly redesigned laser and IPL handpieces, ranging from the CoolView®, Limelight®, Prowave, and Acutip™.

“The original xeo has been a steadfast platform in my practice from the beginning,” said Dr. Mira Kaga, founder of The Kaga Institute of Medicine and Aesthetics. “The enhancements of the xeo+ have allowed me to treat faster and more efficiently, helping to streamline my operations even more and improve ROI. This technology offers a wide range of solutions and is designed to be intuitive, making it suitable for users of all experience levels.”

Addressing the most popular aesthetic concerns, xeo+ offers over 25 solutions for skin revitalization, hair removal, vascular, pigment reduction, and more. The flexibility and customization of applications allow practices the opportunity to widen their patient demographic and evolve with the demands and needs of their patients.

xeo+ is currently available to physicians throughout the US and Canada. Interested providers are encouraged to visit www.cutera.com for more information.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit www.cutera.com/us-en/products/xeo-plus.

Important safety and risk information about xeo+ is available by contacting Cutera at www.cutera.com/us-en/global-offices. Patients should talk to their healthcare provider.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.